Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S317000
Reexamination Certificate
active
07947698
ABSTRACT:
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
REFERENCES:
patent: 7060827 (2006-06-01), Singh et al.
patent: 7122542 (2006-10-01), Singh et al.
patent: 7329671 (2008-02-01), Singh et al.
patent: 7329672 (2008-02-01), Singh et al.
patent: 7332484 (2008-02-01), Singh et al.
patent: 7452879 (2008-11-01), Singh et al.
patent: 2004/0029902 (2004-02-01), Singh et al.
patent: 2005/0209230 (2005-09-01), Singh et al.
patent: 2005/0234049 (2005-10-01), Singh et al.
patent: 2006/0035891 (2006-02-01), Li et al.
patent: 2006/0058525 (2006-03-01), Singh et al.
patent: 2006/0135543 (2006-06-01), Singh et al.
patent: 2006/0167254 (2006-07-01), Cooper et al.
patent: 2006/0211657 (2006-09-01), Singh et al.
patent: 2006/0234983 (2006-10-01), Singh et al.
patent: 2006/0270694 (2006-11-01), Wong
patent: 2006/0293311 (2006-12-01), Li et al.
patent: 2007/0004626 (2007-01-01), Masuda et al.
patent: 2007/0060603 (2007-03-01), Singh et al.
patent: 2007/0117775 (2007-05-01), Payan
patent: 2007/0129360 (2007-06-01), Bhamidipati et al.
patent: 2007/0129362 (2007-06-01), Bhamidipati et al.
patent: 2007/0191405 (2007-08-01), Noronha et al.
patent: 2007/0197782 (2007-08-01), Clough et al.
patent: 2007/0203161 (2007-08-01), Argade et al.
patent: 2007/0203162 (2007-08-01), Li et al.
patent: 2007/0225321 (2007-09-01), Singh et al.
patent: 2007/0225495 (2007-09-01), Singh et al.
patent: 2007/0293520 (2007-12-01), Singh et al.
patent: 2007/0293521 (2007-12-01), Singh et al.
patent: 2007/0293522 (2007-12-01), Singh et al.
patent: 2007/0293523 (2007-12-01), Singh et al.
patent: 2007/0293524 (2007-12-01), Singh et al.
patent: 2007/0299095 (2007-12-01), Singh et al.
patent: 2008/0039622 (2008-02-01), Singh et al.
patent: 2008/0194603 (2008-08-01), Li et al.
patent: 2008/0221089 (2008-09-01), Argade et al.
patent: 2008/0260754 (2008-10-01), Li et al.
patent: 2008/0306099 (2008-12-01), Li et al.
patent: 2006/021454 (2006-03-01), None
patent: WO 2006/021454 (2006-03-01), None
patent: WO 2007/053452 (2007-05-01), None
Vippagunta et al., “Crystalline Solids”, Adv. Drug Del. Rev., 48 (2001) 3-26.
U.S. Appl. No. 11/539,142, filed Oct. 5, 2006, Singh et al.
U.S. Appl. No. 11/539,074, filed Oct. 5, 2006, Singh et al.
U.S. Appl. No. 11/943,506, filed Nov. 20, 2007, Bhamidipati et al.
U.S. Appl. No. 12/028,581, filed Feb. 8, 2008, Argade et al.
U.S. Appl. No. 12/030,031, filed Feb. 12, 2008, Li et al.
U.S. Appl. No. 12/175,441, filed Jul. 17, 2008, Singh et al.
U.S. Appl. No. 12/193,627, filed Aug. 18, 2008, Li et al.
U.S. Appl. No. 12/199,705, filed Aug. 27, 2008, Singh et al.
U.S. Appl. No. 12/268,235, filed Nov. 10, 2008, Singh et al.
U.S. Appl. No. 12/268,218, filed Nov. 10, 2008, Singh et al.
U.S. Appl. No. 12/273,357, filed Nov. 18, 2008, Singh et al.
Atuegbu Andy
Bhamidipati Somasekhar
Carroll David
Clough Jeffrey Wayne
Cooper Robin
Rigel Pharmaceuticals Inc.
Ward Paul V.
Weaver Austin Villeneuve & Sampson LLP
Young Travis
LandOfFree
Compositions and methods for inhibition of the JAK pathway does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibition of the JAK pathway, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibition of the JAK pathway will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670796